Agilent Technologies (A) Return on Capital Employed (2011 - 2026)
Agilent Technologies (A) posted quarterly Return on Capital Employed of 14.57% for Q2 2026, up 44.0% year-over-year from 10.12% in Q2 2025, and up 5.46% quarter-over-quarter from 13.82% in Q1 2026.
Agilent Technologies (A) Return on Capital Employed (2011 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Return on Capital Employed for 16 consecutive years, with 14.57% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Capital Employed rose 44.0% year-over-year to 14.57%; the TTM figure through Apr 2026 stood at 14.57% (up 44.0% YoY), while the FY2025 annual figure was 14.88%, down 93.0% from the prior year.
- Return on Capital Employed improved to 14.57% in Q2 2026 per A's latest filing, from 13.82% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 18.98% in Q1 2023 and bottomed at 13.82% in Q1 2026.
- Historically, Return on Capital Employed has averaged 15.83% across 5 years, with a median of 15.21% in 2022.
- Annual changes were most pronounced in 2022 — Return on Capital Employed soared 365 bps — and 2024, when it plunged 482 bps.
- Agilent Technologies' Return on Capital Employed stood at 18.71% in 2022, then declined by 21 bps to 14.81% in 2023, then increased by 5 bps to 15.62% in 2024, then slipped by 7 bps to 14.6% in 2025, then fell by 0 bps to 14.57% in 2026.
- Business Quant data shows A's Return on Capital Employed at 14.57% in Q2 2026, 13.82% in Q1 2026, and 14.6% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.92 Bn | 209.86 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 140.37 Bn | 136.02 Bn | 3.61 Bn | 6.42% |
| 3 | Idexx Laboratories | 46.17 Bn | 45.97 Bn | 779.09 Mn | 68.60% |
| 4 | Agilent Technologies | 39.76 Bn | 37.96 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 39.41 Bn | 37.33 Bn | 1.44 Bn | 10.49% |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | -16.64% |
| 7 | Illumina | 30.07 Bn | 28.90 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.62 Bn | 28.56 Bn | 650.22 Mn | 49.80% |
| 9 | Quest Diagnostics | 26.15 Bn | 25.53 Bn | 1.03 Bn | 10.85% |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 8.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 14.57% |
| Jan 31, 2026 | 13.82% |
| Oct 31, 2025 | 14.60% |
| Jul 31, 2025 | 14.02% |
| Apr 30, 2025 | 14.14% |
| Jan 31, 2025 | 14.78% |
| Oct 31, 2024 | 15.62% |
| Jul 31, 2024 | 17.43% |
| Apr 30, 2024 | 14.40% |
| Jan 31, 2024 | 14.16% |
| Oct 31, 2023 | 14.81% |
| Jul 31, 2023 | 15.75% |
| Apr 30, 2023 | 18.40% |
| Jan 31, 2023 | 18.98% |
| Oct 31, 2022 | 18.71% |
| Jul 31, 2022 | 18.00% |
| Apr 30, 2022 | 17.10% |
| Jan 31, 2022 | 15.62% |
| Oct 31, 2021 | 15.15% |
| Jul 31, 2021 | 14.35% |